Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.
Goh
Brian K P
BK
D003362:Cost-Benefit Analysis; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000191:economics / Q000601:surgery; D049268:Positron-Emission Tomography / Q000191:economics; D014057:Tomography, X-Ray Computed